AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
Powered by AMiner. Clicking this button will take you away from SciOpen.
Home Cancer Biology & Medicine Article
PDF (153.8 KB)
Cite
EndNote(RIS) BibTeX
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Editorial | Open Access

Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China

Jianbin Li1,2, Zefei Jiang1 ( )
Senior Department of Oncology, Fifth Medical Center of PLA General Hospital, Beijing 100071, China
Department of Medical Molecular Biology, Beijing Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China
Show Author Information

References

【1】
【1】
 
 
Crossref Google Scholar
Cancer Biology & Medicine
Volume 21 Issue 10,
October 2024
Pages 838-843
DOI: 10.20892/j.issn.2095-3941.2024.0374

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Cite this Report
Close
Close
Cite this article:
Li J, Jiang Z. Chinese Society of Clinical Oncology Breast Cancer (CSCO BC) Guidelines in 2024: International Contributions from China. Cancer Biology & Medicine, 2024, 21(10): 838-843. https://doi.org/10.20892/j.issn.2095-3941.2024.0374

758

Views

38

Downloads

10

Crossref

15

Web of Science

16

Scopus
Received: 04 September 2024
Accepted: 04 October 2024
Published: 21 October 2024
©2024 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License